Banca Mediolanum (BMED) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
2 Jun, 2026Executive summary
Net income for the first nine months of 2024 reached €674.3 million, up 18% year-over-year, driven by higher net interest and commission income, and strong market performance.
Total assets under administration and management rose to €133 billion, an 18% increase from September 2023, supported by strong net inflows and favorable market trends.
Customer base grew 5% to over 1.89 million, with 149,000 new customers acquired and strong digital acquisition.
Interim dividend of €0.37 per share approved, totaling approximately €273 million, payable November 20, 2024.
Credit book expanded to €17.2 billion, up 1% from both September and December 2023.
Financial highlights
Net commission income rose 13% to €873.6 million, with recurring fees up 14.5% to €1.13 billion, driven by strong financial markets and net inflows.
Net interest income increased by 13% to €613.4 million, benefiting from higher interest rates and increased lending.
Operating margin reached a record €847.9 million, up 16% year-over-year; contribution margin rose 15% to €1.48 billion.
Total net inflows for the first nine months were €7.16 billion, up 28% year-over-year; managed assets net inflows surged 92% to €5.44 billion.
Cost/income ratio improved to 38.3%; cost of risk at 21 basis points.
Outlook and guidance
Managed asset net inflows expected to reach €7.5 billion for 2024; strong flows anticipated for 2025.
Net interest income projected to grow 8% in 2024, with a 3% decrease expected in 2025 based on current rate curves.
Cost/income ratio targeted below 40%; dividend expected to increase versus prior year, pending board approval.
Performance fees accrued but not crystallized as of November 5th amounted to €230 million.
Management expects a positive profit performance for full-year 2024, supported by stable global growth and continued organic expansion.
Latest events from Banca Mediolanum
- Net income up 24% to €449.9M, CET1 at 23.7%, and managed asset inflows guidance raised.BMED
Q2 20242 Jun 2026 - Net income up 6% to €477.3M, with record assets, strong inflows, and robust capital ratios.BMED
Q2 20252 Jun 2026 - Net income up 10–10.4% YoY to €243.3m, with record inflows and strong capital ratios.BMED
Q1 20252 Jun 2026 - Q1 2026 net income up 13%, with strong margins, inflows, and robust capital ratios.BMED
Q1 20267 May 2026 - Record net income, strong asset growth, and a 25% higher dividend highlight a standout year.BMED
Q4 20253 Feb 2026 - Record net income of €1.12B, €10.44B inflows, and 42% higher dividend proposed.BMED
Q4 20248 Jan 2026 - Net income up 8% to €726M, assets at €150.4B, and interim dividend raised to €0.60/share.BMED
Q3 20258 Nov 2025